[HTML][HTML] Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact

F Cantini, L Niccoli, D Matarrese, E Nicastri… - The Journal of …, 2020 - ncbi.nlm.nih.gov
As discussed in the Journal recently1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

Prolonged virus shedding even after seroconversion in a patient with COVID-19

WD Liu, SY Chang, JT Wang, MJ Tsai… - Journal of …, 2020 - journalofinfection.com
As discussed in the Journal recently 1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

Y Xie, S Cao, H Dong, Q Li, E Chen… - Journal of …, 2020 - journalofinfection.com
As discussed in the Journal recently 1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

[HTML][HTML] Regional air pollution persistence links to COVID-19 infection zoning

A Frontera, C Martin, K Vlachos… - The Journal of infection, 2020 - ncbi.nlm.nih.gov
As discussed in the Journal recently1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19

Z Liu, W Long, M Tu, S Chen, Y Huang… - Journal of …, 2020 - journalofinfection.com
As discussed in the Journal recently 1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

[HTML][HTML] Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study

J Ma, J Yin, Y Qian, Y Wu - The Journal of infection, 2020 - ncbi.nlm.nih.gov
As discussed in the Journal recently1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

[HTML][HTML] Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19

G Lui, L Ling, CKC Lai, EYK Tso, KSC Fung… - The Journal of …, 2020 - ncbi.nlm.nih.gov
As discussed in the Journal recently1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

[HTML][HTML] Rethinking pandemic preparation: Global Health Security Index (GHSI) is predictive of COVID-19 burden, but in the opposite direction

T Aitken, KL Chin, D Liew… - The Journal of infection, 2020 - ncbi.nlm.nih.gov
As discussed in the Journal recently1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2

J Luan, Y Lu, S Gao, L Zhang - Journal of Infection, 2020 - journalofinfection.com
As discussed in the Journal recently 1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is …

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

C Dimeglio, JM Loubes, B Deporte, M Dubois… - Journal of Infection, 2020 - Elsevier
A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting
millions of people and killing thousands. Failure to anticipate the spread of the virus now …